학술논문
1329P FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered NSCLC
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S767-S767
Subject
Language
ISSN
0923-7534